Xalkori - Drug Details
๐Ÿ“Š Estimates Xalkori Dialyzability By Different_Modalities

Xalkori

Complete Drug Information

Drug Name
Xalkori
Trade Names
Xalkori
Pregnancy Category
AU: D
Bioavailability
43%
Routes of Administration
Oral
Protein Binding
91%%
Metabolism
Liver (CYP3A4/CYP3A5-mediated)
Elimination
42 hours
Excretion
Faeces (63%), urine (22%)
Formula
C21H22Cl2FN5O
Molar Mass
450.34
Volume of Distribution
C21H22Cl2FN5O

๐Ÿคฐ Pregnancy Category Information

Category: AU: D

Drugs which have caused, are suspected to have caused, or may be expected to cause an increased incidence of human fetal malformations or irreversible damage. These drugs may also have adverse pharmacological effects.